Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer.
López-Velazco JI, Manzano S, Otaño M, Elorriaga K, Bultó N, Herrero J, Lahuerta A, Segur V, Álvarez-López I, Caffarel MM, Urruticoechea A. López-Velazco JI, et al. Among authors: elorriaga k. Breast Cancer Res. 2024 Jan 3;26(1):3. doi: 10.1186/s13058-023-01756-8. Breast Cancer Res. 2024. PMID: 38173005 Free PMC article.
Sox2 expression in breast tumours and activation in breast cancer stem cells.
Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R, Martin AG. Leis O, et al. Among authors: elorriaga k. Oncogene. 2012 Mar 15;31(11):1354-65. doi: 10.1038/onc.2011.338. Epub 2011 Aug 8. Oncogene. 2012. PMID: 21822303
Colonic mucosal Schwann cell hamartoma.
Vaamonde-Lorenzo M, Elorriaga K, Montalvo I, Bujanda L. Vaamonde-Lorenzo M, et al. Among authors: elorriaga k. J Dig Dis. 2020 Aug;21(8):475-477. doi: 10.1111/1751-2980.12874. Epub 2020 Jun 11. J Dig Dis. 2020. PMID: 32378790 No abstract available.
Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma.
Manterola L, Aguirre P, Larrea E, Arestín M, Gaafar A, Elorriaga K, Goicoechea I, Armesto M, Fernández-Mercado M, Zabalza I, López-Duque JC, Larruskain E, Sistiaga JA, Landa M, Zabala A, Santaolalla F, Municio JA, Ispizua Á, García-Pedrero JM, Rodrigo JP, Lawrie CH. Manterola L, et al. Among authors: elorriaga k. Sci Rep. 2018 Apr 26;8(1):6613. doi: 10.1038/s41598-018-24780-7. Sci Rep. 2018. PMID: 29700339 Free PMC article.
Molecularly determined total tumour load in lymph nodes of stage I-II colon cancer patients correlates with high-risk factors. A multicentre prospective study.
Aldecoa I, Atares B, Tarragona J, Bernet L, Sardon JD, Pereda T, Villar C, Mendez MC, Gonzalez-Obeso E, Elorriaga K, Alonso GL, Zamora J, Planell N, Palacios J, Castells A, Matias-Guiu X, Cuatrecasas M. Aldecoa I, et al. Among authors: elorriaga k. Virchows Arch. 2016 Oct;469(4):385-94. doi: 10.1007/s00428-016-1990-1. Epub 2016 Jul 22. Virchows Arch. 2016. PMID: 27447172 Free PMC article.
Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening.
Alvarez-Urturi C, Andreu M, Hernandez C, Perez-Riquelme F, Carballo F, Ono A, Cruzado J, Cubiella J, Hernandez V, Mao CG, Perez E, Salas D, Andrés M, Bujanda L, Portillo I, Sarasqueta C, Quintero E, Morillas JD, Lanas A, Sostres C, Augé JM, Castells A, Bessa X; COLONPREV study investigators. Alvarez-Urturi C, et al. Dig Liver Dis. 2016 May;48(5):542-551. doi: 10.1016/j.dld.2016.02.001. Epub 2016 Feb 9. Dig Liver Dis. 2016. PMID: 26936343
Endoscopist characteristics that influence the quality of colonoscopy.
Jover R, Zapater P, Bujanda L, Hernández V, Cubiella J, Pellisé M, Ponce M, Ono A, Lanas A, Seoane A, Marín-Gabriel JC, Chaparro M, Cacho G, Herreros-de-Tejada A, Fernández-Díez S, Peris A, Nicolás-Pérez D, Murcia O, Castells A, Quintero E; COLONPREV Study Investigators. Jover R, et al. Endoscopy. 2016 Mar;48(3):241-7. doi: 10.1055/s-0042-100185. Epub 2016 Feb 4. Endoscopy. 2016. PMID: 26845473
Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests.
Castells A, Quintero E, Álvarez C, Bujanda L, Cubiella J, Salas D, Lanas A, Carballo F, Morillas JD, Hernández C, Jover R, Hijona E, Portillo I, Enríquez-Navascués JM, Hernández V, Martínez-Turnes A, Menéndez-Villalva C, González-Mao C, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Sopeña F, González-Rubio F, Seoane-Urgorri A, Grau J, Serradesanferm A, Pozo À, Pellisé M, Balaguer F, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, Carrillo-Palau M, de la Vega-Prieto M, Iglesias R, Amador J, Blanco JM, Sastre R, Ferrándiz J, González-Hernández MJ, Andreu M, Bessa X; COLONPREV Study Investigators. Castells A, et al. Clin Gastroenterol Hepatol. 2014 Oct;12(10):1708-16.e4. doi: 10.1016/j.cgh.2014.03.022. Epub 2014 Mar 27. Clin Gastroenterol Hepatol. 2014. PMID: 24681078 Clinical Trial.
Fecal immunochemical test accuracy in average-risk colorectal cancer screening.
Hernandez V, Cubiella J, Gonzalez-Mao MC, Iglesias F, Rivera C, Iglesias MB, Cid L, Castro I, de Castro L, Vega P, Hermo JA, Macenlle R, Martínez-Turnes A, Martínez-Ares D, Estevez P, Cid E, Vidal MC, López-Martínez A, Hijona E, Herreros-Villanueva M, Bujanda L, Rodriguez-Prada JI; COLONPREV Study Investigators. Hernandez V, et al. World J Gastroenterol. 2014 Jan 28;20(4):1038-47. doi: 10.3748/wjg.v20.i4.1038. World J Gastroenterol. 2014. PMID: 24574776 Free PMC article.
18 results